Source: Myeloma – Hematology Advisor
Researchers sought to determine whether belamaf would improve PFS rates compared with Pd among patients with relapsed/refractory multiple myeloma.
Read More
by | Jun 4, 2023 | Myeloma News | 0 comments
Source: Myeloma – Hematology Advisor
Researchers sought to determine whether belamaf would improve PFS rates compared with Pd among patients with relapsed/refractory multiple myeloma.
Read More